ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models.

Jian L Campian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.